Long-term results of three-part penile prosthesis implantation with Ectopic reservoir placement in the treatment of erectile dysfunction: is supramuscular tubulation a reliable method?

BACKGROUND: Penile prosthesis implantation is the last resort for refractory erectile dysfunction. Reservoir placement is one of the biggest challenges in inflatable penile prosthesis implant surgery in several cases, especially in patients with abnormal pelvic anatomy. Ectopic reservoir placement with supramuscular approach has many advantages in these cases. RESULTS: No complications were encountered except wound site infection in 2 patients which could be controlled with antibiotic treatment. EDITS scores were not statistically different between patients divided into 2-year groups according to follow-up time. Median values of EDITS scores were high in all groups, suggesting that couples had high sexual satisfaction both in the long term and in the short term. CONCLUSIONS: We recommend placement of the supramuscular tube and reservoir through the incision described, especially in patients whose pelvic anatomy has been modified by lower abdominal surgery.

RéSUMé: CONTEXTE: L'implantation d'une prothèse pénienne est le dernier recours pour les dysfonctions érectiles réfractaires. La mise en place d'un réservoir est l'un des plus grands défis de la chirurgie d'implant de prothèse pénienne gonflable dans de nombreux cas, en particulier chez les patientes présentant une anatomie pelvienne anormale. RéSULTATS: Aucune complication n'a été rencontrée, à l'exception d'une infection du site de la plaie chez 2 patients, qui a pu être contrôlée par un traitement antibiotique. Les scores du questionnaire EDITS ne furent pas statistiquement différents entre les patients classés en groupes de 2 ans en fonction du temps de suivi. Les valeurs médianes des scores du questionnaire EDITS étaient élevées dans tous les groupes, ce qui suggère que les couples avaient une satisfaction sexuelle élevée à la fois à court et à long termes. CONCLUSIONS: Nous recommandons la mise en place du tube supramusculaire et du réservoir à travers l'incision décrite, en particulier chez les patients dont l'anatomie pelvienne a été antérieurement modifiée par une chirurgie abdominale basse.

Treatment of giant prostatic urethral stone with prostatolithotomy case report.

INTRODUCTION: The patient with prostatic urethral stones of the size mentioned in the case report is very rare, and there is no standard surgical procedure for patients with giant stones in the prostatic urethra. PRESENTATION OF CASE: A 62-year-old male patient presented to the emergency department with complaints of dysuria and hematuria. Computed tomography showed a prostatic urethral stone measuring 78x48x56 mm. Open prostatolithotomy was performed by extending the bladder incision towards the prostate capsule and the stone was removed. DISCUSSION: Prostate stones can be classified into two types: true prostate stones, which form within the prostate's tissues, and urethral stones, which develop in the prostatic urethra. Urethral stones can be primary (forming in the urethra) or secondary (migrating from the upper urinary tract). CONCLUSION: Treatment options vary based on stone size and patient history, with endoscopy recommended as the primary approach. However, in cases with large stone burdens, open surgical methods may be preferred.

Long term follow-up results of ablation treatment for patients with small renal mass.

OBJECTIVE: The aim of this study is to evaluate the outcome of ablation therapy in our clinic for the treatment of patients with a small renal mass Materials and Methods: We retrospectively evaluated the technic and follow-up data of 30 patients with 36 tumours who underwent Radiofrequency Ablation (RFA) and Microwave Ablation (MWA) in our clinic. Demographic data, ablation type, tumour characteristics, peroperative and postoperative complications and treatment success of the patients were evaluated. RESULTS: A total of 36 tumours who underwent ablation treatments, 23 were treated with RFA, 13 with MWA. The mean tumour size was 28.9 ± 6.92 mm in RFA and 29.3 ± 7.70 mm in MWA. The mean follow-up period was 49.6 ± 24.7 months in patients with RFA and mean follow-up was 16 ± 8.05 months in MWA treatments. The overall success in MWA administration was calculated as 76.9%, while the overall success in RFA was 80%. CONCLUSION: Long-term oncologic efficacy of RFA appears to be successful in the treatment of T1a renal carcinomas. Further studies can be conducted to elucidate the influence of MWA on long-term oncological outcomes.